|
1
|
Offner F, Samoilova O, Osmanov E, Eom HS,
Topp MS, Raposo J, Pavlov V, Ricci D, Chaturvedi S, Zhu E, et al:
Frontline rituximab, cyclophosphamide, doxorubicin, and prednisone
with bortezomib (VR-CAP) or vincristine (R-CHOP) for non-GCB DLBCL.
Blood. 126:1893–1901. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Alizadeh AA, Eisen MB, Davis RE, Ma C,
Lossos IS, Rosenwald A, Boldrick JC, Sabet H, Tran T, Yu X, et al:
Distinct types of diffuse large B-cell lymphoma identified by gene
expression profiling. Nature. 403:503–511. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lee WJ, Won KH, Won CH, Chang SE, Choi JH,
Moon KC, Park CS, Huh J, Suh C and Lee MW: Secondary cutaneous
diffuse large B-cell lymphoma has a higher international prognostic
index score and worse prognosis than diffuse large B-cell lymphoma,
leg type. Acta Derm Venereol. 96:245–250. 2016. View Article : Google Scholar
|
|
4
|
Castillo JJ, Winer ES and Olszewski AJ:
Sites of extranodal involvement are prognostic in patients with
diffuse large B-cell lymphoma in the rituximab era: An analysis of
the Surveillance, Epidemiology and End Results database. Am J
Hematol. 89:310–314. 2014. View Article : Google Scholar
|
|
5
|
Li S, Young KH and Medeiros LJ: Diffuse
large B-cell lymphoma. Pathology. 50:74–87. 2018. View Article : Google Scholar
|
|
6
|
Wang QM, Lian GY, Song Y, Huang YF and
Gong Y: LncRNA MALAT1 promotes tumorigenesis and immune escape of
diffuse large B cell lymphoma by sponging miR-195. Life Sci.
231:1163352019. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Shi X, Cui Z, Liu X, Wu S, Wu Y, Fang F
and Zhao H: LncRNA FIRRE is activated by MYC and promotes the
development of diffuse large B-cell lymphoma via Wnt/β-catenin
signaling pathway. Biochem Biophys Res Commun. 510:594–600. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Qian CS, Li LJ, Huang HW, Yang HF and Wu
DP: MYC-regulated lncRNA NEAT1 promotes B cell proliferation and
lymphomagenesis via the miR-34b5p-GLI1 pathway in diffuse large
B-cell lymphoma. Cancer Cell Int. 20:872020. View Article : Google Scholar
|
|
9
|
Zhao CC, Jiao Y, Zhang YY, Ning J, Zhang
YR, Xu J, Wei W and Kang-Sheng G: Lnc SMAD5-AS1 as ceRNA inhibit
proliferation of diffuse large B cell lymphoma via Wnt/β-catenin
pathway by sponging miR-135b-5p to elevate expression of APC. Cell
Death Dis. 10:2522019. View Article : Google Scholar
|
|
10
|
Wang Y, Zhang M, Xu H, Wang Y, Li Z, Chang
Y, Wang X, Fu X, Zhou Z, Yang S, et al: Discovery and validation of
the tumor-suppressive function of long noncoding RNA PANDA in human
diffuse large B-cell lymphoma through the inactivation of MAPK/ERK
signaling pathway. Oncotarget. 8:72182–72196. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Jiang L, Zhao XH, Mao YL, Wang JF, Zheng
HJ and You QS: Long non-coding RNA RP11-468E2.5 curtails colorectal
cancer cell proliferation and stimulates apoptosis via the JAK/STAT
signaling pathway by targeting STAT5 and STAT6. J Exp Clin Cancer
Res. 38:4652019. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li J, Wang Y, Zhang CG, Xiao H-J, Xiao HJ,
Hu J-M, Hou JM and He JD: Effect of long non-coding RNA Gas5 on
proliferation, migration, invasion and apoptosis of colorectal
cancer HT-29 cell line. Cancer Cell Int. 18:42018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Liu Y, Yin L, Chen C, Zhang X and Wang S:
Long non-coding RNA GAS5 inhibits migration and invasion in gastric
cancer via interacting with p53 protein. Dig Liver Dis. 52:331–338.
2020. View Article : Google Scholar
|
|
14
|
Huang W, Shi Y, Han B, Wang Q, Zhang B, Qi
C and Liu F: LncRNA GAS5-AS1 inhibits glioma proliferation,
migration, and invasion via miR-106b-5p/TUSC2 axis. Hum Cell.
33:416–426. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zheng S, Li M, Miao K and Xu H: lncRNA
GAS5-promoted apoptosis in triple-negative breast cancer by
targeting miR-378a-5p/SUFU signaling. J Cell Biochem.
121:2225–2235. 2020. View Article : Google Scholar
|
|
16
|
Nakamura Y, Takahashi N, Kakegawa E,
Yoshida K, Ito Y, Kayano H, Niitsu N, Jinnai I and Bessho M: The
GAS5 (growth arrest-specific transcript 5) gene fuses to BCL6 as a
result of t(1;3)(q25;q27) in a patient with B-cell lymphoma. Cancer
Genet Cytogenet. 182:144–149. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Dousti F, Shahrisa A, Ansari H, Hajjari M,
Tahmasebi Birgani Y, Mohammadiasl J and Tahmasebi Birgani M: Long
non-coding RNAs expression levels in diffuse large B-cell lymphoma:
An in silico analysis. Pathol Res Pract. 214:1462–1466. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Senousy MA, El-Abd AM, Abdel-Malek RR and
Rizk SM: Circulating long non-coding RNAs HOTAIR, Linc-p21, GAS5
and XIST expression profiles in diffuse large B-cell lymphoma:
Association with R-CHOP responsiveness. Sci Rep. 11:20952021.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Luengo-Gil G, García-Martínez E,
Chaves-Benito A, Conesa-Zamora P, Navarro-Manzano E,
González-Billalabeitia E, García-Garre E, Martínez-Carrasco A,
Vicente V and Ayala de la Peña F: Clinical and biological impact of
miR-18a expression in breast cancer after neoadjuvant chemotherapy.
Cell Oncol (Dordr). 42:627–644. 2019. View Article : Google Scholar
|
|
20
|
Liu Q, Yu W, Zhu S, Cheng K, Xu H, Lv Y,
Long X, Ma L, Huang J, Sun S, et al: Long noncoding RNA GAS5
regulates the proliferation, migration, and invasion of glioma
cells by negatively regulating miR-18a-5p. J Cell Physiol.
234:757–768. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Liang C, Zhang X, Wang HM, Liu XM, Zhang
XJ, Zheng B, Qian GR and Ma ZL: MicroRNA-18a-5p functions as an
oncogene by directly targeting IRF2 in lung cancer. Cell Death Dis.
8:e27642017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Miao WJ, Yuan DJ, Zhang GZ, Liu Q, Ma HM
and Jin QQ: lncRNA CASC2/miR 18a 5p axis regulates the malignant
potential of nasopharyngeal carcinoma by targeting RBBP8. Oncol
Rep. 41:1797–1806. 2019.
|
|
23
|
Liang B, Zhou C, Cui S, Lu H, Xu R, Xue D,
Zou S and He X: Upregulation of miR-18a-5p promotes the
proliferation of prostate cancer via inhibiting the expression of
SLC40A1. Pathol Res Pract. 224:1534482021. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lim EL, Trinh DL, Scott DW, Chu A,
Krzywinski M, Zhao Y, Robertson AG, Mungall AJ, Schein J, Boyle M,
et al: Comprehensive miRNA sequence analysis reveals survival
differences in diffuse large B-cell lymphoma patients. Genome Biol.
16:182015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
He L, Thomson JM, Hemann MT,
Hernando-Monge E, Mu D, Goodson S, Powers S, Cordon-Cardo C, Lowe
SW, Hannon GJ, et al: A microRNA polycistron as a potential human
oncogene. Nature. 435:828–833. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yang J, Hao T, Sun J, Wei P and Zhang H:
Long noncoding RNA GAS5 modulates α-Solanine-induced
radiosensitivity by negatively regulating miR-18a in human prostate
cancer cells. Biomed Pharmacother. 112:1086562019. View Article : Google Scholar
|
|
27
|
Sood R, Kamikubo Y and Liu P: Role of
RUNX1 in hematological malignancies. Blood. 129:2070–2082. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Seo W, Ikawa T, Kawamoto H and Taniuchi I:
Runx1-Cbfβ facilitates early B lymphocyte development by regulating
expression of Ebf1. J Exp Med. 209:1255–1262. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Miao YS, Zhao YY, Zhao LN, Wang P, Liu YH,
Ma J and Xue YX: MiR-18a increased the permeability of BTB via
RUNX1 mediated down-regulation of ZO-1, occludin and claudin-5.
Cell Signal. 27:156–167. 2015. View Article : Google Scholar
|
|
30
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
31
|
Zhu Q, Li Y, Guo Y, Hu L, Xiao Z, Liu X,
Wang J, Xu Q and Tong X: Long non-coding RNA SNHG16 promotes
proliferation and inhibits apoptosis of diffuse large B-cell
lymphoma cells by targeting miR-497-5p/PIM1 axis. J Cell Mol Med.
23:7395–7405. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Meng H, Zhao B and Wang Y: FOXM1-induced
upregulation of lncRNA OR3A4 promotes the progression of diffuse
large B-cell lymphoma via Wnt/β-catenin signaling pathway. Exp Mol
Pathol. 115:1044512020. View Article : Google Scholar
|
|
33
|
Gao H, Sun Y, Chen J, Jin H and Yang W:
Long non-coding RNA AFAP1-AS1 promotes cell growth and inhibits
apoptosis by binding to specific proteins in germinal center
B-cell-like diffuse large B-cell lymphoma. Am J Transl Res.
12:8225–8246. 2020.
|
|
34
|
Li J, Yang C, Li Y, Chen A, Li L and You
Z: LncRNA GAS5 suppresses ovarian cancer by inducing inflammasome
formation. Biosci Rep. 38:382018.
|
|
35
|
Li G, Cai Y, Wang C, Huang M and Chen J:
LncRNA GAS5 regulates the proliferation, migration, invasion and
apoptosis of brain glioma cells through targeting GSTM3 expression.
The effect of LncRNA GAS5 on glioma cells. J Neurooncol.
143:525–536. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zhao W, Shan B, He D, Cheng Y, Li B, Zhang
C and Duan C: Recent progress in characterizing long noncoding RNAs
in cancer drug resistance. J Cancer. 10:6693–6702. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Yang Y, Shen Z, Yan Y, Wang B, Zhang J,
Shen C, Li T, Ye C, Gao Z, Peng G, et al: Long non-coding RNA GAS5
inhibits cell proliferation, induces G0/G1 arrest and apoptosis,
and functions as a prognostic marker in colorectal cancer. Oncol
Lett. 13:3151–3158. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Tian L, He Y, Zhang H, Wu Z, Li D and
Zheng C: Comprehensive analysis of differentially expressed
profiles of lncRNAs and mRNAs reveals ceRNA networks in the
transformation of diffuse large B-cell lymphoma. Oncol Lett.
16:882–890. 2018.PubMed/NCBI
|
|
39
|
Gu J, Wang Y, Wang X, Zhou D, Wang X, Zhou
M and He Z: Effect of the LncRNA GAS5-MiR-23a-ATG3 axis in
regulating autophagy in patients with breast cancer. Cell Physiol
Biochem. 48:194–207. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Wang X, Jiang X, Zhou L, Wang Z, Huang H
and Wang M: LncRNA NEF is involved the regulation of gastric
carcinoma cell proliferation by targeting RUNX1. Mol Med Rep.
19:2051–2056. 2019.PubMed/NCBI
|
|
41
|
Zhang Y, Qian W, Feng F, Cao Q, Li Y, Hou
Y, Zhang L and Fan J: Upregulated lncRNA CASC2 may inhibit
malignant melanoma development through regulating miR-18a-5p/RUNX1.
Oncol Res. 27:371–377. 2019. View Article : Google Scholar
|
|
42
|
Teng H, Wang P, Xue Y, Liu X, Ma J, Cai H,
Xi Z, Li Z and Liu Y: Role of HCP5-miR-139-RUNX1 feedback loop in
regulating malignant behavior of glioma cells. Mol Ther.
24:1806–1822. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Xu G, Wang H, Yuan D, Yao J, Meng L, Li K,
Zhang Y, Dang C and Zhu K: RUNX1-activated upregulation of lncRNA
RNCR3 promotes cell proliferation, invasion, and suppresses
apoptosis in colorectal cancer via miR-1301-3p/AKT1 axis in vitro
and in vivo. Clin Transl Oncol. 22:1762–1777. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Friedman AD: Cell cycle and developmental
control of hematopoiesis by Runx1. J Cell Physiol. 219:520–524.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Keita M, Bachvarova M, Morin C, Plante M,
Gregoire J, Renaud MC, Sebastianelli A, Trinh XB and Bachvarov D:
The RUNX1 transcription factor is expressed in serous epithelial
ovarian carcinoma and contributes to cell proliferation, migration
and invasion. Cell Cycle. 12:972–986. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Asciolla JJ, Renault TT and Chipuk JE:
Examining BCL-2 family function with large unilamellar vesicles. J
Vis Exp. 68:42912012.
|
|
47
|
Wu D, Ozaki T, Yoshihara Y, Kubo N and
Nakagawara A: Runt-related transcription factor 1 (RUNX1)
stimulates tumor suppressor p53 protein in response to DNA damage
through complex formation and acetylation. J Biol Chem.
288:1353–1364. 2013. View Article : Google Scholar :
|
